Entacapone

Entity type image
Type: Keyphrase
Name: Entacapone
First reported Mar 14 2013 - Updated Mar 14 2013 - 1 reports
Cardinal Health Inc
Cardinal Health Inc

COMTAN (Entacapone) Tablet, Film Coated [Cardinal Health]

Updated Date: Mar 14, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Mar 14 2013]
First reported Feb 07 2013 - Updated Feb 08 2013 - 1 reports

Human medicines European Public Assessment Report (EPAR): Entacapone Teva, entacapone, Revision: 1, Authorised

[Published Pending EC decisions and European Public Assess ... - Feb 07 2013]
Entities: Entacapone
First reported Dec 24 2012 - Updated Dec 24 2012 - 1 reports
Mylan Incorporated
Mylan Incorporated

Mylan settles entacaponepatent litigation with Orion Corporation

Mylan Pharmaceuticals Inc., a subsidiary of Mylan Inc. has entered into a settlement agreement with Orion Corporation to resolve patent litigation related to entacapone tablets, 200 mg. Entacapone tablets are the generic version of Orion's Comtan, indicated ... [Published PharmaBiz - Dec 24 2012]

Quotes

...Transit was delayed in ten of these eleven subjects. The authors observed: "when there was delayed esophageal transit of tablets, the initial absorption of acetaminophen (measured as AUC over the first 60 min) was lower than that after normal esophageal transit of tablets. The peak plasma acetaminophen concentration was also lower and occurred 90 min later when transit was delayed. These kinetic changes decrease the effectiveness of acetaminophen as an analgesic." See K S Channer and C J Roberts, "Effect of Delayed Esophageal Transit on Acetaminophen Absorption" Clinical Pharmacology and Therapeutics 37, 72-76...
Solid dosage form that promotes reliable oral, esophageal and GI transit [Published PharmCast - Mar 14 2013]
Dr. Habil Khorakiwala, founder chairman and group chief executive officer of Wockhardt, said, "Pursuant to a settlement of the litigation between Wockhardt and Orion Corp., Wockhardt will launch an authorized generic version from Sept 30, 2012, with 180-days of exclusivity." Khorakiwala claimed that Wockhardt was the first to file with paragraph-IV certification on the product
Indian drugmaker Wockhardt gets FDA approval for Parkinson’s drug Comtan [Published Topnews.in - Aug 21 2012]

More Content

All (9) | News (4) | Reports (0) | Blogs (5) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Chasing the cure for Parkinson’s disease [Published PMLive - May 21 2013]
Deals of the Week Wants Cash on the Barrelhead [Published The IN VIVO Blog - Mar 22 2013]
Solid dosage form that promotes reliable oral, ... [Published PharmCast - Mar 14 2013]
COMTAN (Entacapone) Tablet, Film Coated [Cardin... [Published DailyMed Drug Label Updates for the last seven ... - Mar 14 2013]
Human medicines European Public Assessment Repo... [Published Pending EC decisions and European Public Assess ... - Feb 08 2013]
Human medicines European Public Assessment Repo... [Published Pending EC decisions and European Public Assess ... - Feb 07 2013]
Human medicines European Public Assessment Repo... [Published Pending EC decisions and European Public Assess ... - Feb 07 2013]
Mylan settles entacaponepatent litigation with ... [Published PharmaBiz - Dec 24 2012]
Indian drugmaker Wockhardt gets FDA approval fo... [Published Topnews.in - Aug 21 2012]
1
In Focus
  •  
Habil Khorakiwala, Malcolm Brenner, Sten Stovall, [more]
  •  
Cardinal Health Inc, Mylan Incorporated, Orion Corp, [more]
  •  
Federal Trade Commission, US Department of Justice, Cancer Research UK, [more]
  •  
L-Dopa, Carbidopa, Litigation, [more]
  •  
Comtan, Stalevo, Glucophage, [more]
  •  
Bristol, Long Beach (California, United States), London, [more]
  •  
United States, Finland, United Kingdom, [more]
  •  
Diseases, Medication, Research & Development, [more]
  •  
Health, Pharma & Biotech
Pending EC decisions and European Public Assess..., DailyMed Drug Label Updates for the last seven ..., PharmaBiz, [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Deals of the Week Wants Cash on the Barrelhead [Published The IN VIVO Blog - Mar 22 2013]
 For pharmas making all but the largest acquisitions, cash is king. From speculative buyouts of preclinical start-ups all the way through bolt-on deals worth a few billion dollars, pharmas typically spend cash rather than swap stock to make their acquisitions. ...
COMTAN (Entacapone) Tablet, Film Coated [Cardin... [Published DailyMed Drug Label Updates for the last seven ... - Mar 14 2013]
Updated Date: Mar 14, 2013 EST ...
Human medicines European Public Assessment Repo... [Published Pending EC decisions and European Public Assess ... - Feb 08 2013]
Human medicines European Public Assessment Repo... [Published Pending EC decisions and European Public Assess ... - Feb 07 2013]
Human medicines European Public Assessment Repo... [Published Pending EC decisions and European Public Assess ... - Feb 07 2013]
1
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.